Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model

被引：0
|
作者：
Dunay, IR
Heimesaat, MM
Bushrab, FN
Müller, RH
Stocker, H
Arasteh, K
Kurowski, M
Fitzner, R
Borner, K
Liesenfeld, O
机构：
[1] Charite, Dept Med Microbiol & Immunol Infect, Inst Infect Med, Berlin, Germany
[2] Free Univ Berlin, Dept Pharmaceut Biotechnol & Qual Management, D-1000 Berlin, Germany
[3] Vivantes Auguste Viktoria Klinikum, HIV Lab, Berlin, Germany
[4] Inst Clin CHem & Pathobiochem, Berlin, Germany
来源：
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY | 2004年 / 294卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis
    Dunay, IR
    Heimesaat, MM
    Bushrab, FN
    Müller, RH
    Stocker, H
    Arasteh, K
    Kurowski, M
    Fitzner, R
    Borner, M
    Liesenfeld, O
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4848 - 4854
  • [2] CLINDAMYCIN IN A MURINE MODEL OF TOXOPLASMIC ENCEPHALITIS
    HOFFLIN, JM
    REMINGTON, JS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) : 492 - 496
  • [3] AN ANIMAL-MODEL FOR REACTIVATION OF TOXOPLASMIC RETINOCHLOROIDITIS AND THE USE OF ATOVAQUONE AS A PROPHYLACTIC AGENT
    PAVESIO, CE
    GORMLEY, PD
    LIGHTMAN, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S787 - S787
  • [4] Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS
    Torres, RA
    Weinberg, W
    Stansell, J
    Leoung, G
    Kovacs, J
    Rogers, M
    Scott, J
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) : 422 - 429
  • [5] Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy
    Duval, X
    Pajot, O
    Le Moing, V
    Longuet, P
    Ecobichon, JL
    Mentre, F
    Leport, C
    Vilde, JL
    AIDS, 2004, 18 (09) : 1342 - 1344
  • [6] Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance
    Katlama, C
    Mouthon, B
    Gourdon, D
    Lapierre, D
    Rousseau, F
    Allegre, T
    Drobacheff, C
    Monlun, E
    Malamud, P
    Salles, B
    Rogez, JF
    GranetBrunello, P
    Cotte, L
    Chaumentin, G
    Leclerc, V
    Tollinchi, F
    Moreau, J
    Dhiver, C
    Durand, JM
    Xeridat, B
    Ravaux, I
    Reynes, J
    Winter, C
    Rabaud, C
    Raffi, F
    Fuzibert, JG
    Vinti, H
    Gougeard, C
    Perichon, I
    Gilquin, J
    Chapuis, L
    Jeantils, V
    Gregoire, V
    Chaput, S
    DeTruchis, P
    Picard, O
    Cros, H
    BorsaLebas, F
    Lafeuillade, A
    Averous, S
    Bourez, JM
    Prazuck, T
    AIDS, 1996, 10 (10) : 1107 - 1112
  • [7] A RETROSPECTIVE STUDY OF PRIMARY AND MAINTENANCE THERAPY OF TOXOPLASMIC ENCEPHALITIS WITH ORAL CLINDAMYCIN AND PYRIMETHAMINE
    FOPPA, CU
    BINI, T
    GREGIS, G
    LAZZARIN, A
    ESPOSITO, R
    MORONI, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (03) : 187 - 189
  • [8] PROTECTIVE RECONSTITUTION OF THE SCID MOUSE AGAINST REACTIVATION OF TOXOPLASMIC ENCEPHALITIS
    BEAMAN, MH
    ARAUJO, FG
    REMINGTON, JS
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02): : 375 - 383
  • [9] Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice
    Araujo, FG
    Suzuki, Y
    Remington, JS
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (05) : 394 - 397
  • [10] EVALUATION OF THE EFFICACY AND SAFETY OF CLINDAMYCIN PLUS PYRIMETHAMINE FOR INDUCTION AND MAINTENANCE THERAPY OF TOXOPLASMIC ENCEPHALITIS IN AIDS
    KATLAMA, C
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (03) : 189 - 191
12345